Skye Bioscience (SKYE) announced the Board has appointed independent director Paul Grayson as Skye’s new Chairman of the Board, effective October 25, 2024. Grayson currently serves as a member of Skye’s Audit, Compensation and Nominating and Corporate Governance Committees. Punit Dhillon, Skye’s Chief Executive Officer, will continue to serve as a member of the Board.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SKYE:
- Skye Bioscience Approves Incentive Plan Amendments and Leadership Changes
- Rising High: RIV Capital, Cansortium launch MOODS brand in New York
- Skye Bioscience started with an Outperform at Scotiabank on nimacimab potential
- Skye Bioscience initiated with an Outperform at Scotiabank
- Skye Bioscience provides perspectives on prospects for nimacimab
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
